Insulin glargine, recombinant Subcutaneous and Stendra
Determining the interaction of Insulin glargine, recombinant Subcutaneous and Stendra and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine, recombinant Subcutaneous-Sterapred
- Insulin glargine, recombinant Subcutaneous-Sterapred DS
- Insulin glargine, recombinant Subcutaneous-Sterile Saline Diluent Tip-Lok Syringe
- Insulin glargine, recombinant Subcutaneous-Stieva-A Cream Forte Topical
- Insulin glargine, recombinant Subcutaneous-Stieva-A Cream Topical
- Insulin glargine, recombinant Subcutaneous-Stieva-A Gel Topical
- Stendra-Insulin glulisine
- Stendra-Insulin Glulisine (Cartridges and Pens)
- Stendra-Insulin Glulisine (Vials)
- Stendra-Insulin glulisine Subcutaneous
- Stendra-Insulin human inhaled Inhalation
- Stendra-Insulin human regular Injection